Compare ALLO & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | RLGT |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 291.6M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | RLGT |
|---|---|---|
| Price | $1.38 | $6.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $8.67 | $8.00 |
| AVG Volume (30 Days) | ★ 2.5M | 158.6K |
| Earning Date | 11-06-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.35 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | ★ $925,786,000.00 |
| Revenue This Year | N/A | $3.77 |
| Revenue Next Year | $100.00 | $3.51 |
| P/E Ratio | ★ N/A | $21.03 |
| Revenue Growth | N/A | ★ 16.42 |
| 52 Week Low | $0.86 | $5.44 |
| 52 Week High | $3.78 | $7.94 |
| Indicator | ALLO | RLGT |
|---|---|---|
| Relative Strength Index (RSI) | 49.50 | 54.14 |
| Support Level | $1.32 | $6.46 |
| Resistance Level | $1.52 | $6.84 |
| Average True Range (ATR) | 0.10 | 0.16 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 28.57 | 40.04 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.